News & Events

Sheila Mikhail will moderate and speak on panels at the Phacilitate Cell & Gene Therapy Forum in Washington, DC. The panels are entitled "Exploring Alternate Mechanisms for Cell and Gene Therapy Companies" and "Case study: Asklêpios BioPharmaceutical and NanoCor Therapeutics."

Nilay Patel published an article in the June 2007 issue of IP Links entitled "Patent Licensing Strategies in View of Medimmune v. Genentech". The article offers licensors several modifications to consider in order to mitigate the effects of this seminal Supreme Court decision.

Sheila Mikhail was a featured speaker at the Phacilitate Cell & Gene Therapy Forum. The forum, held in Baltimore, Maryland, intends to promote safe, commercially-viable cell and gene therapy products. Mikhail, the Managing Member of Life Sciences Law, presented on finding ways to secure funding for orphan disease indications, such as by identifying foundation funding opportunities and by seeking private sponsors.

Sheila Mikhail, Managing Member of Life Sciences Law, was a featured speaker on a panel discussing emerging trends in bio-therapeutics research and opportunities for industry and academia collaboration at the Industry Collaboration Symposium. The symposium, hosted by Ohio State University Medical Center, was designed to highlight biomedical technologies that are developing but are in need of commercial partnerships.

In conjunction with the Canadian Consulate, Sheila Mikhail presented an installment in a program meant to provide insight into the clinical trial process in Canada. Mikhail, the Managing Member of Life Sciences Law, compared the FDA’s and Health Canada’s Clinical Trial regulations and regulatory practices. The program was held at the North Carolina Biotechnology Center.

The Managing Member of Life Sciences Law, Sheila Mikhail, was a featured speaker on a panel of female CEOs for Triangle Commercial Real Estate Women. Mikhail participated in discussions about the obstacles women have historically faced in the corporate environment.

Life Sciences Law presented a roundtable discussion as part of its Clinical Trials Lunch Series. The discussion, held at the North Carolina Biotechnology Center, focused on the critical issues in clinical trials agreements.

Sheila Mikhail, the Managing Member of Life Sciences Law, presented at the BIO Mid-America VentureForum in Cleveland, Ohio. The conference was designed to educate its attendees on the challenges that bioscience companies encounter and on trends in the industry’s financial markets.